# QCR Holdings Inc: financial statements, quarterly

QCRH · Nasdaq · CIK 906465 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/qcrh.md) · [Financials](/companies/qcrh/financials.md) · [Filings](/companies/qcrh/filings.md) · [Insiders](/companies/qcrh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/qcrh/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [135](/filings/0001558370-24-015002.md) | [160 d](/filings/0001558370-24-002208.md) | [142](/filings/0001558370-24-007504.md) | [151](/filings/0001558370-24-011521.md) | [153](/filings/0001558370-24-015002.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [53.3](/filings/0001558370-23-018207.md) | [56.5 d](/filings/0001558370-24-002208.md) | [60.4](/filings/0001558370-24-007504.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.8](/filings/0001558370-24-015002.md) | [4.5 d](/filings/0001104659-26-021531.md) | [1.2](/filings/0001558370-25-007110.md) | [2.6](/filings/0001558370-25-010884.md) | [2.0](/filings/0001104659-25-108483.md) | [3.0 d](/filings/0001104659-26-021531.md) | [0.3](/filings/0001104659-26-057779.md) | [1.6](/filings/0001104659-26-092545.md) | [3.8](/filings/0001104659-25-108483.md) | [3.0 d](/filings/0001104659-26-021531.md) | [2.4](/filings/0001104659-26-057779.md) | [3.2](/filings/0001104659-26-092545.md) |
| Net income | $m | [25.1](/filings/0001558370-24-015002.md) | [32.9 d](/filings/0001104659-26-021531.md) | [26.7](/filings/0001104659-25-108483.md) | [29.1](/filings/0001104659-25-108483.md) | [27.8](/filings/0001104659-25-108483.md) | [30.2 d](/filings/0001104659-26-021531.md) | [25.8](/filings/0001104659-26-092545.md) | [29.0](/filings/0001104659-26-092545.md) | [36.7](/filings/0001104659-25-108483.md) | [35.7 d](/filings/0001104659-26-021531.md) | [33.4](/filings/0001104659-26-092545.md) | [36.3](/filings/0001104659-26-092545.md) |
| Diluted EPS | $ per share | [1.49](/filings/0001558370-24-015002.md) | not reported | [1.58](/filings/0001558370-25-007110.md) | [1.72](/filings/0001558370-25-010884.md) | [1.64](/filings/0001104659-25-108483.md) | not reported | [1.52](/filings/0001104659-26-057779.md) | [1.71](/filings/0001104659-26-092545.md) | [2.16](/filings/0001104659-25-108483.md) | not reported | [1.99](/filings/0001104659-26-057779.md) | [2.19](/filings/0001104659-26-092545.md) |
| Basic EPS | $ per share | [1.50](/filings/0001558370-24-015002.md) | not reported | [1.59](/filings/0001558370-25-007110.md) | [1.73](/filings/0001558370-25-010884.md) | [1.65](/filings/0001104659-25-108483.md) | not reported | [1.53](/filings/0001104659-26-057779.md) | [1.71](/filings/0001104659-26-092545.md) | [2.17](/filings/0001104659-25-108483.md) | not reported | [2.00](/filings/0001104659-26-057779.md) | [2.20](/filings/0001104659-26-092545.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [8,540](/filings/0001558370-24-015002.md) | [8,539](/filings/0001104659-26-021531.md) | [8,600](/filings/0001558370-25-007110.md) | [8,872](/filings/0001558370-25-010884.md) | [9,089](/filings/0001104659-25-108483.md) | [9,026](/filings/0001104659-26-021531.md) | [9,082](/filings/0001104659-26-057779.md) | [9,180](/filings/0001104659-26-092545.md) | [9,568](/filings/0001104659-25-108483.md) | [9,498](/filings/0001104659-26-092545.md) | [9,614](/filings/0001104659-26-057779.md) | [9,521](/filings/0001104659-26-092545.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $m | [7,712](/filings/0001558370-23-018207.md) | [7,652](/filings/0001558370-25-001954.md) | [7,692](/filings/0001558370-24-007504.md) | [7,936](/filings/0001558370-24-011521.md) | [8,112](/filings/0001558370-24-015002.md) | [8,029](/filings/0001104659-26-021531.md) | [8,130](/filings/0001558370-25-007110.md) | [8,192](/filings/0001558370-25-010884.md) | [8,481](/filings/0001104659-25-108483.md) | [8,386](/filings/0001104659-26-092545.md) | [8,491](/filings/0001104659-26-057779.md) | [8,371](/filings/0001104659-26-092545.md) |
| Short-term borrowings | $m | [0.5](/filings/0001558370-23-018207.md) | [1.5](/filings/0001558370-25-001954.md) | [2.7](/filings/0001558370-24-007504.md) | [1.6](/filings/0001558370-24-011521.md) | [2.8](/filings/0001558370-24-015002.md) | [1.8](/filings/0001104659-26-021531.md) | [2.1](/filings/0001558370-25-007110.md) | [1.4](/filings/0001558370-25-010884.md) | [2.9](/filings/0001104659-25-108483.md) | [2.7](/filings/0001104659-26-092545.md) | [2.0](/filings/0001104659-26-057779.md) | [8.9](/filings/0001104659-26-092545.md) |
| Shareholders' equity | $m | [828](/filings/0001558370-24-015002.md) | [887](/filings/0001104659-26-021531.md) | [907](/filings/0001104659-25-108483.md) | [936](/filings/0001104659-25-108483.md) | [977](/filings/0001104659-25-108483.md) | [997](/filings/0001104659-26-092545.md) | [1,023](/filings/0001104659-26-092545.md) | [1,051](/filings/0001104659-26-092545.md) | [1,087](/filings/0001104659-25-108483.md) | [1,112](/filings/0001104659-26-092545.md) | [1,122](/filings/0001104659-26-092545.md) | [1,150](/filings/0001104659-26-092545.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Current liabilities: not reported
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [24.9 d](/filings/0001558370-24-015002.md) | [291 d](/filings/0001104659-26-021531.md) | [2.7](/filings/0001558370-25-007110.md) | [26.3 d](/filings/0001558370-25-010884.md) | [238 d](/filings/0001104659-25-108483.md) | [177 d](/filings/0001104659-26-021531.md) | [(3.6)](/filings/0001104659-26-057779.md) | [42.2 d](/filings/0001104659-26-092545.md) | [47.5 d](/filings/0001104659-25-108483.md) | [335 d](/filings/0001104659-26-021531.md) | [4.4](/filings/0001104659-26-057779.md) | [471 d](/filings/0001104659-26-092545.md) |
| Capital expenditure | $m | [3.3 d](/filings/0001558370-24-015002.md) | [6.9 d](/filings/0001104659-26-021531.md) | [12.1](/filings/0001558370-25-007110.md) | [10.2 d](/filings/0001558370-25-010884.md) | [8.2 d](/filings/0001104659-25-108483.md) | [13.9 d](/filings/0001104659-26-021531.md) | [9.1](/filings/0001104659-26-057779.md) | [18.0 d](/filings/0001104659-26-092545.md) | [15.7 d](/filings/0001104659-25-108483.md) | [24.6 d](/filings/0001104659-26-021531.md) | [12.3](/filings/0001104659-26-057779.md) | [13.4 d](/filings/0001104659-26-092545.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [17.1](/filings/0001558370-23-018207.md) | [16.9](/filings/0001558370-24-007504.md) | [16.8](/filings/0001558370-24-011521.md) | [16.8](/filings/0001558370-24-015002.md) | [16.9](/filings/0001558370-25-007110.md) | [16.9](/filings/0001558370-25-010884.md) | [17.0](/filings/0001104659-25-108483.md) | [17.0](/filings/0001104659-26-057779.md) | [17.0](/filings/0001104659-26-092545.md) | [17.0](/filings/0001104659-25-108483.md) | [16.7](/filings/0001104659-26-057779.md) | [16.6](/filings/0001104659-26-092545.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 16,375,614 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001104659-26-092545.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.